Evaluation of the efficacy of simvastatin use in Systemic Sclerosis patients: A Randomized Clinical Trial
Not Applicable
- Conditions
- Systemic Sclerosis
- Registration Number
- RBR-36qz3p
- Lead Sponsor
- Sociedade Brasileira de Reumatologia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Diagnosis of Systemic Sclerosis according to the American College of Rheumatology; minimum and maximum age between eighteen and seventy years of age; serum total cholesterol levels up to 200mg/dl; written consent to participate in the study
Exclusion Criteria
Pregnant women; intolerance or allergy to simvastatin or its derivatives; being in use or having used it for less than 30 days; diabetes mellitus; heart failure; renal failure; hypertension; myopathies; hypothyroidism; smoking
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method